MOTS-c 40mg: What This Mitochondrial Peptide Is and How Researchers Use It

MOTS-c 40mg refers to a 40-milligram vial of the synthetic mitochondrial-derived peptide MOTS-c, which is sold strictly as a laboratory research compound and not as a medicine. The 40 mg figure describes how much lyophilized powder is in the vial, not a dose anyone is meant to take at once. No human dosing protocol for MOTS-c has been established in peer-reviewed clinical trials, and the peptide is not FDA-approved for human use in the United States.

What MOTS-c Is and Why It Gets Studied

MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It is a 16-amino-acid peptide encoded in mitochondrial DNA, which makes it unusual among the signaling molecules researchers typically study.

Laboratory work in cells and rodents has examined MOTS-c for its role in metabolic homeostasis, AMPK signaling, and insulin sensitivity. To dig into the proposed biology, a primer on how does mots c work covers the pathways most often cited in the literature.

MOTS-c is a research chemical. It is not a treatment, cure, or approved therapy for any condition, and animal findings do not automatically translate to people.

What a 40 mg Vial Means in Practice

Vendors list MOTS-c in several vial sizes, and 40 mg is one of the larger research formats. A mots c 10mg vial is the small pilot size that labs often order first when they are validating an assay.

Because a 40 mg vial contains far more peptide than a single experiment needs, reconstitution and serial dilution matter. Typical handling in a lab looks like this:

• Add bacteriostatic water or sterile diluent slowly down the inside wall of the vial.
• Swirl gently — do not vortex or shake, since peptides can aggregate.
• Calculate concentration from the volume added, then dilute to working strength in single-use aliquots.
• Freeze unused portions in small aliquots to avoid repeated freeze-thaw cycles.

The mots-c peptide 40mg format is popular mainly because it reduces how often a lab has to reorder, not because it implies a bigger dose.

How MOTS-c Compares With Other Research Peptides

MOTS-c is usually evaluated alongside other metabolic and mitochondrial compounds rather than on its own. A comparison such as aod 9604 vs mots-c comes up because both are studied in fat-metabolism and energy-balance models, even though their proposed mechanisms differ.

Some laboratories investigate ss-31 and mots-c together, since both compounds are associated with mitochondrial function but act through distinct pathways. Others compare MOTS-c against SLU-PP-332, a synthetic ERR agonist, or against Lipo-C lipotropic blends; in each case, the measured readouts — glucose handling, AMPK activation, body composition in rodents — are what get reported.

Dosage in Published Research — and Why It Is Not a Human Protocol

Most rodent studies that use MOTS-c deliver roughly 0.5 mg/kg of body weight, often once daily by subcutaneous or intraperitoneal injection, for anywhere from one to several weeks. Any mots c dosage chart you find online is summarizing animal data, not a validated human schedule.

Dose translation from mice to humans is not a simple multiplication. Body surface area, clearance, and half-life differ between species, and MOTS-c has not cleared the early-phase human trials that would establish a safe range.

Routes of Administration Used in Research

Injection is the standard route in animal work. Subcutaneous delivery is common because it is reproducible, while intraperitoneal injection is used when faster absorption is needed inside a short study window.

An experimental mots-c nasal spray formulation has appeared in vendor catalogs, but intranasal delivery of peptides faces absorption and stability questions that remain unresolved in the published literature. Researchers should treat nasal products as unverified formats rather than interchangeable with injectable research material.

Storage, Handling, and Sourcing Quality

Lyophilized MOTS-c should be stored frozen, typically at -20 C for shorter periods and -80 C for long-term storage, protected from light and moisture. Once reconstituted, most labs keep working aliquots refrigerated for short-term use and freeze the remainder.

• Check the certificate of analysis for purity, usually reported by HPLC, plus mass confirmation by mass spectrometry.
• Confirm the fill size — a 40 mg label should match measured peptide content, not total vial weight.
• Avoid vendors that make health claims, promise results, or sell without third-party testing.
• Record lot numbers so results can be traced if a batch performs inconsistently.

Safety, Legal Status, and What to Know

MOTS-c is not FDA-approved for human use in the United States. It is sold as a research chemical for in vitro and animal studies, and products labeled "for research use only" are not intended for human consumption.

Reported side effects in humans are essentially undocumented because controlled human studies are lacking. Anyone considering off-label use of any research peptide should consult a licensed healthcare professional rather than relying on forum reports or vendor marketing.

Personal importation and possession rules vary by state and country, and a research label does not make a peptide legal to use as a supplement or drug. Buyers should verify institutional and local requirements before ordering.

The Bottom Line

A MOTS-c 40mg vial is a bulk laboratory format of a mitochondrial-derived research peptide, not a 40 mg human dose. Researchers dilute it heavily, follow animal-model dosing from the literature, and treat every finding as preliminary until human data exist.

MOTS-c remains an investigational compound with no approved medical use, and safety information in people is limited to absent.